Top singer Justin Bieber joins the long list of celebrities seeking their fortune in the burgeoning cannabis business. The 27-year-old Canadian singer has struck a deal with American cannabis brand Palms to produce a “high-end” line of joints called Peaches as his latest hit.
Justin Bieber lancia Peaches
The special cigarettes are available in a pack of seven and a personalized Bic lighter with the song title will also be included. The collaboration between Justin Bieber and the brand is alimited edition, made with the contribution of both to the Last Prisoners Project and the Veterans Walk and Talk. “Our goal is to make cannabis more accessible and help destigmatize its use»Reads a press release from the company. The Bieber-signed joints will initially only go on sale in California, where the use of marijuana is legal for those over the age of 21.
Bieber is the latest in a long list of celebrities who have entered into partnerships with the nascent legal cannabis industry. Country music legend Willie Nelson has launched a wide range of cannabis products under his Willie’s Reserve brand. Rapper Jay-Z is the CEO of the California weed company The Parent Company, and famed chef and entrepreneur Martha Stewart has launched a range of cannabidiol-rich gums in partnership with Canopy Growth Corp. Recreational use of cannabis is legal in about one third of US states.
How to invest in cannabis
Many analysts predict massive growth for the cannabis industry. Notably New Frontier, a Washington-based cannabis research company, predicts that Total sales of legal cannabis in the US will exceed $ 35 billion by 2025.
In light of this huge growth potential, many see marijuana as a golden investment opportunity – but not without risk. It is important to remember that the use and sale of marijuana, despite state laws, is still illegal even in Italy. Currently, the medical marijuana market offers strong short-term income potential. But the recreational side continues to attract investors.
One of the biggest risks of investing in marijuana is that its growing popularity can also be attractive to scammers. The SEC, the U.S. Consob, has issued a warning listing several fraudulent marijuana-related investment schemes, including unlicensed sellers, unsolicited investment offers, and market manipulation.
Other risks for those wishing to invest in marijuana to consider are first and foremost the fact that as long as marijuana is illegal, it will continue to be difficult for marijuana companies to access credit. Then there is a legislative risk: as stated on Business Insider, Kenny Polcari, founder and Managing Partner of Kace Capital Advisors, the future taxation is a big question mark. “Right now you can buy marijuana without paying any sales tax.” But “taxes will raise the price of marijuana for the end user.” And, if too high, these added costs could turn some consumers off.
Finally, an assessment risk: many of the companies that are involved in the production or sale of marijuana are young. What should their ratings be? It’s hard to say. Just like investing in any stock, even to bet on cannabis you will need a broker and careful due diligence before choosing investments, which means taking the time to research each company and staying up to date on the latest regulations.
The best current titles? According to Forbes, Amyris which has gained nearly 450% in the last year, has been working to create synthetic cannabinoids that could revolutionize the industry and make it less dependent on large and expensive growing facilities. With a market cap of $ 4.5 billion, Amyris’ latest quarterly results recorded a 74.4% increase in sales over the previous quarter. Headlights also focused on Curaleaf Holdings Inc, Headquartered in Massachusetts and listed on the Canadian Securities Exchange, it operates dispensaries and manufacturing facilities in 23 states, and with a market capital of CAD 10.3 billion is one of the largest players in the industry in North America. Also good Cronos e GrowGeneration Corp.